Revolutionizing Drug Design To Make Personalized Medicine Affordable!

The challenges in the pharmaceutical industry for any new drug development has been hampered by inefficiency in the design pipeline, resulting in increased costs, longer development time and poor efficacy. Over 90% failures of drugs at Clinical Phase II and the sheer small number of new drugs clearing FDA every year emphasizes the urgency of the situation and calls for a new development methodology in the early stages of the design and validation. Ceremorphic created an architecture with its proprietary analog technology to better predict outcomes early on to increase the R&D efficiency of the whole process. This innovation will transform the future of drug discovery to accelerate making personalized medicine a reality!